Oral opioid use is common among patients with SPRA, ankylosing spondylitis, and PsA and is associated with an increased risk for mortality.

Studies involving multiple aspects of plaque psoriasis evolution, persistence, and progression have produced clues and ...

The study’s small size limits interpretation, but it remains the largest real-world data available, experts said.